AZD8205 in combination with AZD9574 + AZD8205 in combination with AZD9574 plus rilvegostomig (AZD2936)

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

AZD8205 in combination with AZD9574 + AZD8205 in combination with AZD9574 plus rilvegostomig (AZD2936)
Treatment and conditionWhere it standsTrials
AZD8205 in combination with AZD9574 + AZD8205 in combination with AZD9574 plus rilvegostomig (AZD2936) for endometrial neoplasmsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1